These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11723223)

  • 1. Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist.
    Heise CE; Santos WL; Schreihofer AM; Heasley BH; Mukhin YV; Macdonald TL; Lynch KR
    Mol Pharmacol; 2001 Dec; 60(6):1173-80. PubMed ID: 11723223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.
    Yokoyama K; Baker DL; Virag T; Liliom K; Byun HS; Tigyi G; Bittman R
    Biochim Biophys Acta; 2002 May; 1582(1-3):295-308. PubMed ID: 12069841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential targeting of lysophosphatidic acid LPA
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
    Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
    J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.
    Heasley BH; Jarosz R; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2735-40. PubMed ID: 15125924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for lysophosphatidic acid receptor antagonist selectivity.
    Sardar VM; Bautista DL; Fischer DJ; Yokoyama K; Nusser N; Virag T; Wang DA; Baker DL; Tigyi G; Parrill AL
    Biochim Biophys Acta; 2002 May; 1582(1-3):309-17. PubMed ID: 12069842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
    Okusa MD; Ye H; Huang L; Sigismund L; Macdonald T; Lynch KR
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F565-74. PubMed ID: 12770838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures.
    Guillot E; Le Bail JC; Paul P; Fourgous V; Briand P; Partiseti M; Cornet B; Janiak P; Philippo C
    J Pharmacol Exp Ther; 2020 Aug; 374(2):283-294. PubMed ID: 32409422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of lysophosphatidic acid analogs.
    Lynch KR; Macdonald TL
    Biochim Biophys Acta; 2002 May; 1582(1-3):289-94. PubMed ID: 12069840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
    ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.
    Santos WL; Heasley BH; Jarosz R; Carter KM; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3473-6. PubMed ID: 15177455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid acts on LPA
    Chabowski DS; Kadlec AO; Ait-Aissa K; Hockenberry JC; Pearson PJ; Beyer AM; Gutterman DD
    Br J Pharmacol; 2018 Nov; 175(22):4266-4280. PubMed ID: 30153326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
    Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
    J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
    Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
    Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid signaling via LPA
    Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
    Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.
    Alcántara-Hernández R; Hernández-Méndez A; Campos-Martínez GA; Meizoso-Huesca A; García-Sáinz JA
    PLoS One; 2015; 10(10):e0140583. PubMed ID: 26473723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Edg-Like LPA Receptor-Ligand Interactions.
    Balogh B; Pazmany T; Matyus P
    Curr Pharm Des; 2015; 21(24):3533-47. PubMed ID: 25686617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
    Lin CI; Chen CN; Lin PW; Chang KJ; Hsieh FJ; Lee H
    Biochem Biophys Res Commun; 2007 Nov; 363(4):1001-8. PubMed ID: 17923111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.